FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

377246002: Brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride 2mg/10mg/12.5mg liquid (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2752042019 Brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride 2mg/10mg/12.5mg liquid (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2770982018 Brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride 2mg/10mg/12.5mg liquid en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride 2mg/10mg/12.5mg liquid Is a Dexbrompheniramine maleate false Inferred relationship Some
    Brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride 2mg/10mg/12.5mg liquid Is a Product containing dextromethorphan hydrobromide false Inferred relationship Some
    Brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride 2mg/10mg/12.5mg liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Dexbrompheniramine maleate (substance) false Inferred relationship Some
    Brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride 2mg/10mg/12.5mg liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Dextromethorphan hydrobromide (substance) false Inferred relationship Some
    Brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride 2mg/10mg/12.5mg liquid Is a Product containing phenyl propanolamine hydrochloride false Inferred relationship Some
    Brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride 2mg/10mg/12.5mg liquid Is a Product containing brompheniramine maleate false Inferred relationship Some
    Brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride 2mg/10mg/12.5mg liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Brompheniramine (substance) false Inferred relationship Some
    Brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride 2mg/10mg/12.5mg liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Phenylpropanolamine hydrochloride false Inferred relationship Some
    Brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride 2mg/10mg/12.5mg liquid Is a Brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride false Inferred relationship Some
    Brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride 2mg/10mg/12.5mg liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Brompheniramine maleate false Inferred relationship Some
    Brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride 2mg/10mg/12.5mg liquid Has manufactured dose form Liquide oral false Inferred relationship Some
    Brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride 2mg/10mg/12.5mg liquid Is a Product manufactured as oral dose form (product) false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start